Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 9134079, 6 pages
https://doi.org/10.1155/2017/9134079
Research Article

Plasma IL-37 Elevated in Patients with Chronic Heart Failure and Predicted Major Adverse Cardiac Events: A 1-Year Follow-Up Study

1Department of Cardiology, The First Affiliated Hospital Medical College of Xi’an Jiaotong University, Xi’an 710061, China
2Department of Cardiology, Shaanxi Province People’s Hospital and The Third Affiliated Hospital Medical College of Xi'an Jiaotong University, Xi’an 710068, China

Correspondence should be addressed to Chaofeng Sun; moc.361@napnapnahw

Received 4 October 2016; Accepted 30 May 2017; Published 11 July 2017

Academic Editor: Truc Nguyen

Copyright © 2017 Xiling Shou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. W. Yancy, M. Jessup, B. Bozkurt et al., “2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines,” Circulation, vol. 128, no. 16, pp. 1810–1852, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. S. A. Dick and S. Epelman, “Chronic heart failure and inflammation: what do we really know?” Circulation Research, vol. 119, no. 1, pp. 159–176, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. P. C. Westman, M. J. Lipinski, D. Luger et al., “Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction,” Journal of the American College of Cardiology, vol. 67, no. 17, pp. 2050–2060, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. A. A. El-Menyar, “Cytokines and myocardial dysfunction: state of the art,” Journal of Cardiac Failure, vol. 14, no. 1, pp. 61–74, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. N. R. Rose, “Critical cytokine pathways to cardiac inflammation,” Journal of Interferon and Cytokine Research, vol. 31, no. 10, pp. 705–710, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. M. F. Nold, C. A. Nold-Petry, J. A. Zepp, B. E. Palmer, P. Bufler, and C. A. Dinarello, “IL-37 is a fundamental inhibitor of innate immunity,” Nature Immunology, vol. 11, no. 11, pp. 1014–1022, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Boraschi, D. Lucchesi, S. Hainzl et al., “IL-37: a new anti-inflammatory cytokine of the IL-1 family,” European Cytokine Network, vol. 22, no. 3, pp. 127–147, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Ye, B. Jiang, J. Deng et al., “IL-37 alleviates rheumatoid arthritis by suppressing IL-17 and IL-17-triggering cytokine production and limiting Th17 cell proliferation,” Journal of Immunology, vol. 194, no. 11, pp. 5110–5119, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Song, F. Qi, Y. Fan et al., “Glucocorticoid regulates interleukin-37 in systemic lupus erythematosus,” Journal of Clinical Immunology, vol. 33, no. 1, pp. 111–117, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. D. B. Ballak, J. A. v. Diepen, A. R. Moschen et al., “IL-37 protects against obesity-induced inflammation and insulin resistance,” Nature Communications, vol. 5, p. 4711, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Chai, Q. Ji, H. Zhang et al., “The protective effect of interleukin-37 on vascular calcification and atherosclerosis in apolipoprotein E-deficient mice with diabetes,” Journal of Interferon and Cytokine Research, vol. 35, no. 7, pp. 530–539, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. Q. Ji, Q. Zeng, Y. Huang et al., “Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome,” Mediators of Inflammation, vol. 2014, Article ID 165742, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Wu, K. Meng, Q. Ji et al., “Interleukin-37 ameliorates myocardial ischaemia/reperfusion injury in mice,” Clinical and Experimental Immunology, vol. 176, no. 3, pp. 438–451, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Xu, A. Wang, F. Jiang, J. Hu, and X. Zhang, “Effects of interleukin-37 on cardiac function after myocardial infarction in mice,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 5, pp. 5247–5251, 2015. View at Google Scholar
  15. S. L. Kumar, P. C. McDonnell, R. Lehr et al., “Identification and initial characterization of four novel members of the interleukin-1 family,” The Journal of Biological Chemistry, vol. 275, no. 14, pp. 10308–10314, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. A. M. Bulau, M. F. Nold, S. Li et al., “Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 7, pp. 2650–2655, 2014. View at Google Scholar
  17. X. Teng, Z. Hu, X. Wei et al., “IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production,” Journal of Immunology, vol. 192, no. 4, pp. 1815–1823, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. O. Gjesdal, D. A. Bluemke, and J. A. Lima, “Cardiac remodeling at the population level - risk factors, screening, and outcomes,” Nature Reviews Cardiology, vol. 8, pp. 673–685, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Kalogeropoulos, V. Georgiopoulou, B. M. Psaty et al., “Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study,” Journal of the American College of Cardiology, vol. 55, no. 19, pp. 2129–2137, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Serrano-Rios and A. Corbaton, “Diabetes mellitus, heart failure and mortality,” Medicina Clínica, vol. 125, no. 5, pp. 182-183, 2005. View at Google Scholar
  21. J. L. Januzzi, R. v. Kimmenade, J. Lainchbury et al., “NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study,” European Heart Journal, vol. 27, pp. 330–337, 2006. View at Google Scholar
  22. A. Maisel, “B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what’s next?” Circulation, vol. 105, no. 20, pp. 2328–2331, 2002. View at Publisher · View at Google Scholar · View at Scopus